ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 318

HLA-B27 Subtypes in Enthesitis Related Arthritis Category of Juvenile Idiopathic Arthritis

Rajni Srivastava1, Shikha Agnihotry2, Rakesh Aggarwal3 and Amita Aggarwal1, 1Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 2Bioinformatics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 3Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), human leukocyte antigens (HLA) and juvenile idiopathic arthritis (JIA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose: HLA-B27 has a high degree of genetic polymorphism, with more than 105 known subtypes. Enthesitis Related Arthritis (ERA) is most common form of Juvenile Idiopathic Arthritis (JIA) in Asian and Indian population. It has strong association with HLA B27 similar to the adult ankylosing spondylitis (AS). Since the disease occurs in children and different HLA B27 subtypes confer different susceptibility to AS we studied the HLA-B27 subtypes associated with ERA and AS to see if there is any difference.

Methods: Samples were collected from 135 patients with ERA and 121 patients with AS. Genomic DNA was isolated from whole blood using salting out technique and HLA B27 typing was done using ARMS-PCR. Primers for intronic region of HLA-DR were used as internal control. HLA-B27 subtyping was done by sequencing using a group-specific amplification of the second and third exon region of HLA B27 gene.

Results: Hundred and seven out of 135 patients with ERA (79%) and 102/121 (84%) of AS patients were HLA B27 positive. HLA B*2705 and 04 were the most common subtypes. HLA B2*27:02, 07 and 018 were seen rarely. The frequency of HLAB*27:05 was 70% in ERA as compared to 56.8% in AS (p=0.032) whereas HLAB*27:04 was 21.4% in ERA and 36.2% in AS (p=0.013). No correlation was seen between B*27 subtypes (B*2704 and B*2705) and clinical features of JIA-ERA.

Conclusion: HLAB*27 subtype frequencies are different in ERA and AS. It is possible that the presence of ancestral subtype HLA B*27:05 leads to early onset of disease.


Disclosure:

R. Srivastava,
None;

S. Agnihotry,
None;

R. Aggarwal,
None;

A. Aggarwal,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hla-b27-subtypes-in-enthesitis-related-arthritis-category-of-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology